BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Hemophilia Alliance - ECPv6.3.7//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Hemophilia Alliance
X-ORIGINAL-URL:https://hemoalliance.org
X-WR-CALDESC:Events for Hemophilia Alliance
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231107T140000
DTEND;TZID=America/New_York:20231107T150000
DTSTAMP:20260404T092826
CREATED:20231023T165946Z
LAST-MODIFIED:20231023T165946Z
UID:45791-1699365600-1699369200@hemoalliance.org
SUMMARY:🟥 Member Webinar : Hemophilia Alliance Hosts - A Webinar from Pfizer - Case Studies of Using BeneFix® (Coagulation Factor IX [Recombinant]) in Different Hemophilia B Patient Populations in an Evolving Treatment Landscape – Is There More to the Story?
DESCRIPTION:Date: Tuesday\, November 7\, 2023\nTime: 2:00pm – 3:00pm ET \n\n \nTITLE:\nCase Studies of Using BeneFix® (Coagulation Factor IX [Recombinant]) in Different Hemophilia B Patient Populations in an Evolving Treatment Landscape – Is There More to the Story? \nSPEAKER:\n\nDoris Quon\, MD \nMedical Director of the Orthopaedic Hemophilia Treatment Center at the Luskin Orthopaedic Institute for Children in Los Angeles\, California
URL:https://hemoalliance.org/alliance-events/a-webinar-from-pfizer-case-studies-of-using-benefix-coagulation-factor-ix-recombinant-in-different-hemophilia-b-patient-populations-i/
CATEGORIES:Members Only,Webinar
END:VEVENT
END:VCALENDAR